Back to search

Article

Nintedanib and Pirfenidone Affect Growth and Differentiation of Human Alveolar Type 2 Cells

2026-03-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterized by epithelial cell senescence. Pirfenidone and nintedanib are approved drugs for the treatment of IPF. They significantly slow disease progression, but their mechanisms of action, especially on alveolar type 2 (AT2) cells, are poorly understood. We addressed this question by evaluating c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69b7cb63-161a-5c4e-b9ac-a2b6b08248fb
DOI
10.64898/2026.03.02.708135
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nintedanib and Pirfenidone Affect Growth and Differentiation of Human Alveolar Type 2 CellsDOI 10.64898/2026.03.02.708135
Select a neighboring publication to make it the new centre.